KBLI 46447 is not on the closed, conditional, SME-reserved, or partnership schedules of Pres. Reg. 10/2021. That clears the ownership layer — PT PMA is structurally available. Sector regulators may still add overlays (see layer 02 below).
Licensing runs through BPOM + Kemenkes under Permenkes 14/2021 + Permenkes 1148/2011 — not via the standard OSS RBA risk matrix. Capital floors, timelines, and ongoing obligations differ materially from the BKPM Reg. 5/2025 default. Wholesale of pharmaceutical raw materials for humans and animals.
Operating this code requires Indonesian-credentialed practitioners on staff (STPT / STR / SIPA / Penanggung Jawab Teknis depending on sub-activity). PT PMA can hold the corporate licence but cannot operate without Indonesian-citizen credential holders. Most foreign investors recruit Indonesian PJs on payroll, partner with existing operators, or pivot to an adjacent KBLI.
Worth confirming: Openness here is based on BUPM (Pres. Reg. 10/2021). Sector regulators (PSE/Kominfo for digital platforms, BPOM for food and cosmetics, OJK for financial, Kemenkes for healthcare, Permendag for retail, ESDM for energy) often add licensing and capital requirements on top — the practical answer depends on your business model. Talk to our team
Perdagangan Besar Bahan Farmasi Untuk Manusia Dan Hewan
Last updated · Sourced from OSS Indonesia
This group includes wholesale trading businesses of pharmaceutical raw materials for both humans and animals.
Operating license routes through Ministry of Trade, not OSS — Emerhub handles the application end-to-end.
Importer Identification Number (API-U for traders, API-P for own-use) required for cross-border trade.
Distribution agreements with overseas principals must be registered with Kemendag (STP).
Foreign-owned wholesalers can operate under PT PMA but face restrictions on direct retail.
Indonesia's BUPM (Investment Business Fields) regulation places this code into one of five tracks. The track determines whether a foreign investor (PMA) can operate in this activity at all, and under what conditions.
KBLI 46447 is not on Indonesia's closed, conditional, SME-reserved, or partnership-required schedules under BUPM (Pres. Reg. 10/2021). A foreign investor can incorporate a PT PMA under this code, but sector regulators (PSE/Kominfo, BPOM, OJK, Kemenkes, Permendag, ESDM) almost always add licensing and capital requirements on top — the practical answer depends on your specific business model.
Wholesale of pharmaceutical raw materials for humans and animals
Note. Same PBF + Apoteker requirement as KBLI 46441 — operating requires an Indonesian-licensed pharmacist (Apoteker STRA + SIPA) as the Penanggung Jawab Teknis. PT PMA can hold the corporate licence; the responsible-pharmacist role cannot be filled by a foreign practitioner.
BKPM Reg. 5/2025's default is IDR 2.5 billion paid-up + IDR 10 billion commitment per KBLI. The figure above is the binding override for this activity — the higher number wins.
Sub-activities recorded under this KBLI in the OSS regulatory database. The classification covers any business operating in one or more of these areas.
From the official OSS scope definition for this KBLI class. Each item is a distinct sub-activity that falls under this code.
Emerhub is a corporate-services provider in Indonesia. We do the legal and regulatory legwork for foreign investors so you can focus on the business itself. Here's what the engagement looks like.
We confirm KBLI 46447 is the right primary code for your business, advise on secondary codes you may also need, and finalize the holding structure with you before any filing.
We draft the Articles of Association before a notary, register the entity with the Ministry of Law & Human Rights (Kemenkumham), and obtain the company's tax ID (NPWP). Under BKPM Reg. 5/2025, paid-up capital is IDR 2.5 billion (~USD 160K) — the cash actually deposited at incorporation. The IDR 10 billion+ figure many sources still cite is the total investment commitment per KBLI, realised over time via your LKPM reports.
Specific permits, application requirements and ongoing obligations vary by business scale and the sub-activity within this KBLI. We file these on your behalf — this section is for transparency on what we'll be handling. Switch between scales below; by default we show Large (the PMA scale).
Wholesale trader of pharmaceutical raw materials for humans
Documents and capabilities you must demonstrate at registration
Compliance and reporting duties throughout operation
The authority that issues the license depends on your situation.
| Authority | Applies when |
|---|---|
| Minister/Head of Agency | All |
| Minister/Head of Agency | Foreign Investment |
PB UMKU permits sit on top of the main NIB and Sertifikat Standar — each is issued by a different ministry, and only when a specific operational activity is performed. This KBLI carries 4 candidate permits across 3 regulators; most operations only need a handful. Emerhub maps your operation to the exact set, files them, and tracks renewals.
BPOM (National Agency of Drug & Food Control). Applies to drugs, processed food, traditional medicine, cosmetics, and health supplements — produced, imported, repackaged, or distributed for human consumption. BPOM is the gating regulator; product registration is required before any commercial sale.
Ministry of Marine Affairs & Fisheries (KKP). Applies to capture fishing, aquaculture, fish processing, fish-feed production, and live-fish trade. The Processing Feasibility Certificate (SKP) is the gating quality permit for fish processors.
Ministry of Agriculture. Applies if you produce, import, distribute, or sell animal medicines, vaccines, or feed; if you breed livestock; or if you operate a veterinary practice. A "veterinary control number" (NKV) is the entry-point permit for animal-product processors.

We file the OSS application with KBLI 46447 as your primary business activity, complete the risk-based assessment, and collect the NIB (Business Identification Number) for you — typically within hours of submission. You don't need to touch the OSS portal.
NIB is issued for the preparation stage. Commercial operation requires a full Operating License (Izin) issued by the competent ministry after a substantive review of the operator's capability, facility, and compliance. Operating with NIB alone exposes the entity to penalties, blacklisting, and contract invalidation. We prepare the application bundle, liaise with the competent ministry, and chase issuance through to the certificate. Statutory turnaround: 4 business days — real-world timing typically runs longer when site inspections or additional clarifications are requested.
Post-launch we run your monthly tax filings, quarterly LKPM (Investment Activity Reports), annual general meeting (RUPS), and any sector-specific reporting. You get a single point of contact and a monthly compliance digest — no Indonesian-language paperwork on your desk.
A plain-English explanation of this classification and the businesses it covers.
KBLI 46447 (Perdagangan Besar Bahan Farmasi Untuk Manusia Dan Hewan) is the 5-digit Indonesian Standard Industrial Classification code for wholesale trade of pharmaceutical raw materials for humans and animals. It sits within Wholesale and Retail Trade; Repair and Maintenance of Cars and Motorcycles under the subgroup Wholesale Trade of Pharmaceuticals, Medicines, and Cosmetics (major group 46) in the official KBLI 2020 taxonomy maintained by Statistics Indonesia (BPS).
Any Indonesian or foreign-owned entity that intends to operate in wholesale trade of pharmaceutical raw materials for humans and animals as a primary or secondary business activity must select this code on its NIB (Business Identification Number). The selected code determines the licensing instruments required, the issuing authority, and the ongoing compliance obligations.
Indonesia's OSS Risk-Based Approach uses the KBLI code to determine three things: (1) whether foreign investment is permitted and at what cap, (2) the risk-based licensing instruments required, and (3) the authority that issues each instrument. Choosing the wrong code can delay or invalidate your license.
Indonesia's BPS published the new KBLI 2025 taxonomy in early 2025. OSS, BKPM and the operating ministries have not yet adopted it — KBLI 2020 remains the active standard for business registration. This is what's coming for this specific code.
KBLI 46447 does not carry the same number forward into KBLI 2025 — the activity has been reclassified, but the precise mapping isn't recorded in our database yet.
When OSS adopts KBLI 2025, we'll migrate your existing entity to the appropriate successor code as part of ongoing compliance — no action needed on your end now.
Talk to a specialistIndonesia's OSS Risk-Based Approach assigns a separate risk level for each of the four business scales. The licensing instruments required (NIB, Standard Certificate, Operating License) are determined by the risk level. Foreign-owned entities (PT PMA) must register at the Large scale, so the rightmost column applies to most foreign investors.
KBLI 46447 (Perdagangan Besar Bahan Farmasi Untuk Manusia Dan Hewan) is the 5-digit Indonesian Standard Industrial Classification code for wholesale trade of pharmaceutical raw materials for humans and animals. It sits within the Wholesale and Retail Trade; Repair and Maintenance of Cars and Motorcycles category in the official KBLI 2020 taxonomy maintained by Badan Pusat Statistik (BPS).
Yes — KBLI 46447 is open to foreign investment, but the licensing path runs entirely through BPOM + Kemenkes under Permenkes 14/2021 + Permenkes 1148/2011, not OSS RBA. BKPM Reg. 5/2025's IDR 2.5 billion default does NOT apply to this code; the binding capital floor is set by BPOM + Kemenkes and is materially higher (see the capital question below).
KBLI 46447's risk levels per business scale: Micro High, Small High, Medium High, Large High. Foreign-owned entities (PT PMA) must register at the Large scale.
NIB + Operating Licence (Izin). KBLI 46447 is High risk at Large scale, so the Operating Licence requires substantive sector-regulator approval before the business can operate. Expect a multi-month review with technical submissions. To obtain the licensing instrument, OSS lists 14 application requirements (persyaratan). The first few: Documents for the responsible pharmacist include: a. Pharmacist Registration Certificate (STRA) b.…; Business location data, including: <ol> <li>Office of the Pharmaceutical Distribution Business (PBF) for…; Proof of Payment for Non-Tax State Revenue (PNBP), and 11 more — see the full list with supporting documents in the Licensing detail section. 4 sector-specific PB UMKU permits also apply depending on the exact activity. See the requirements summary at the top of the page.
Sector regulator override: BKPM Reg. 5/2025 default (IDR 2.5 billion paid-up) required by BPOM + Kemenkes under Permenkes 14/2021 + Permenkes 1148/2011 (PBF). This is higher than BKPM Reg. 5/2025's default IDR 2.5 billion paid-up; the higher number wins. See the investment status block for the ownership context.
PT PMA setup typically takes 4-8 weeks: AHU registration (1-2 weeks), NIB issuance via OSS (immediate to 1 week), bank account opening (2-4 weeks). The licensing cycle for KBLI 46447 specifically takes 4 days at the Large business scale.
Not on the Tax Holiday or Tax Allowance priority lists. KBLI 46447 businesses pay the standard 22% PPh Badan; Super Tax Deduction (300% R&D / 200% vocational training) may still apply for qualifying expenses.
Authority depends on the investor profile. For PMA: Minister/Head of Agency. For domestic SME scale: typically Governor (for Provincial scope) or Regent/Mayor (Regency/City scope). See the licensing detail section for the full per-permit authority routing.
Beyond the NIB, KBLI 46447 carries 4 PB UMKU permits across 3 sector regulators: Pharmaceuticals (2), Marine & Fisheries (1), Veterinary & Animal Medicine (1). Most operations only need 2-4 of these. The relevant set depends on which specific activities you actually perform; Emerhub maps the right subset before filing. See the full PB UMKU list for per-permit detail and regulator routing.
KBLIs in the same subgroup 4644: 46441 (Wholesale Trade of Pharmaceutical Drugs for Humans); 46442 (Wholesale Trade of Traditional Medicine for Humans); 46443 (Wholesale Trade of Cosmetics for Humans); 46444 (Wholesale Trade of Pharmaceutical Drugs for Animals); 46445 (Wholesale Trade of Traditional Medicine for Animals). These are closely related activities — see the related-codes section below for full list.